Abuse deterrent (or deterrence) testing is an important component of addressing the serious and growing public health problem of abuse and misuse of prescription products. We provide independent, non-biased testing conducted by experts especially for abuse deterrent formulations using real-world methodologies. Our three main areas of focus are:
Pseudoephedrine Formulations
- API extractability
- Multiple methods
- Conversion to methamphetamine
- HI/P
- Lithium in ammonia
- “One-pot”

Opioid Formulations
- Evaluation of intact and adulterated formulations
- Dissolution testing
- Tablet hardness
- Crushability
- Syringeability/viscosity
- Vaporization
- Particle size analysis
- Extractability

Other Controlled Substances Formulations
- Formulation-specific evaluations

For more information about some of our capabilities, please see our recent announcement under the Publications section. We have significant experience in evaluating abuse deterrent formulations using real-world methodologies. We also offer all the techniques necessary to fully assess a new formulation’s performance and can act as an independent test source for new products. In addition to dissolution testing, we offer tablet hardness, crushablility, syringeability/viscosity, vaporization, particle size analysis, and extractability. We can also assist with formulation design.
To learn more, please contact us at info@improvedpharma.com.